|
|
Pharma Pricing & Market Access Outlook Europe 2011 is the biggest pricing, reimbursement and market access conference in the world. The conference, being organized by Health Network Communications in association with the London School of Economics, will delve the health policy framework governing market access for medicines. The event will provide excellent opportunity for the delegates to network with the leading pricing & reimbursement, market access and health policy professionals and to discuss the latest global trends in the Life Sciences industry. It will also ensure that delegates have a comprehensive understanding of the international P&R environment and will give expert advice on how to work in this ever changing healthcare environment.
The Pharma Pricing & Market Access Outlook Europe 2011 conference will focus on several topics, such as:
• Conclusions of EU Commission High Level Pharma Forum; their implementation and the impact on the market access environment
• Price regulation and reform in the UK: view from small / mid size pharma
• UK; Health Technology Appraisal in the UK
• France; latest developments in pricing and reimbursement policy
• Germany; latest developments in pricing and reimbursement policy
• Improving efficiency and performance in national pharmaceutical policy
• Netherlands; latest developments in pricing and reimbursement policy
• Sweden; latest changes in reimbursement and pricing policy legislation
• USA; latest developments in pricing and reimbursement policy
• Canada: latest developments in pricing and reimbursement policy
• Comparing European, US and Canadian pricing, reimbursement and HTA environments
• The patient’s perspective in reimbursement assessments
• Price reform in Europe: the role of industry
• Italy; latest developments in pricing policy regulations
• Spain; latest developments in pricing policy regulations
• China; latest developments in pricing and reimbursement policy
• Russia; pricing and reimbursement policy in Russia
• Pricing and reimbursement strategies for obtaining market access
• More effective use of pharmacoeconomic data in pricing and reimbursement application
• How to use health economic data for evidence based decision making?
Visitor Profile
The visitors profile at the Pharma Pricing & Market Access Outlook Europe 2011 would include:
- Consultants
- Scientists
- Pharmacists
- Students
- General Public
- Researchers
- Government Health officials
- Distributors
- Dealers
- Suppliers
Organizer
Health Network Communications
